UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of report (Date of earliest event reported): July 29, 2014
Acadia
Healthcare Company, Inc.
(Exact
Name of Registrant as Specified in Its Charter)
|
Delaware |
001-35331 |
46-2492228 |
|
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
830 Crescent Centre Drive, Suite 610, Franklin, Tennessee 37067
(Address
of Principal Executive Offices)
(615) 861-6000
(Registrant's
Telephone Number, including Area Code)
Not Applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02 |
Results of Operations and Financial Condition. |
On July 29, 2014, Acadia Healthcare Company, Inc. (“Acadia”) issued a press release announcing, among other things, Acadia’s operating and financial results for the second quarter and six months ended June 30, 2014. The press release is furnished herewith as Exhibit 99 hereto and is incorporated herein by reference.
|
Item 9.01 |
Financial Statements and Exhibits. |
| (d) | Exhibits. |
| 99 | Press Release of Acadia Healthcare Company, Inc., dated July 29, 2014. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
ACADIA HEALTHCARE COMPANY, INC. |
||||
|
|
||||
| Date: July 29, 2014 | By: |
/s/ Christopher L. Howard |
||
|
Christopher L. Howard |
||||
|
Executive Vice President and General Counsel |
||||
EXHIBIT INDEX
|
Exhibit |
||
|
No. |
Description |
|
| 99 |
Press Release of Acadia Healthcare Company, Inc., dated July 29, 2014 |
Exhibit 99
Acadia Healthcare Reports Second Quarter Adjusted EPS Increase of 23.1% to $0.32 on 20.5% Growth in Revenue
Same Facility Revenue Increases 11.5%
Affirms 2014 Adjusted Earnings Guidance in Range of $1.44 to $1.46 per Diluted Share
FRANKLIN, Tenn.--(BUSINESS WIRE)--July 29, 2014--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the second quarter and six months ended June 30, 2014. For the quarter, revenue was $213.8 million, up 20.5% from $177.5 million for the second quarter of 2013. Income from continuing operations was $22.5 million, or $0.43 per diluted share, for the second quarter of 2014 compared with $12.3 million, or $0.24 per diluted share, for the second quarter of 2013. Adjusted income from continuing operations rose 26.8% to $16.6 million for the second quarter of 2014 from $13.1 million for the second quarter of 2013, while adjusted income from continuing operations per diluted share increased 23.1% to $0.32 from $0.26. The adjusted results exclude a gain on foreign currency derivatives of $13.7 million for the second quarter of 2014 related to Acadia’s recent acquisition of Partnerships in Care (PiC), as well as transaction-related expenses of $3.0 million and $1.4 million for the second quarter of 2014 and 2013, respectively. A reconciliation of all GAAP and non-GAAP financial results in this release is on pages 8 and 9.
Revenue for the first six months of 2014 grew 22.6% to $415.2 million from $338.7 million for the comparable period in 2013. Income from continuing operations was $35.5 million, or $0.69 per diluted share, for the first half of 2014 compared with $16.3 million, or $0.33 per diluted share, for the first half of 2013. Adjusted income from continuing operations was $30.6 million for the first six months of 2014, up 29.3% from $23.7 million for the first six months of 2013, while adjusted income from continuing operations per diluted share increased 27.7% to $0.60 from $0.47. The adjusted results exclude a gain on foreign currency derivatives of $13.7 million for the first six months of 2014, debt extinguishment costs of $9.4 million for the first six months of 2013 and transaction-related expenses of $4.6 million and $2.8 million for the first half of 2014 and 2013, respectively.
“We are pleased to report a continuation of strong operating and financial results for Acadia’s second quarter,” said Joey Jacobs, Chairman and Chief Executive Officer of Acadia. “Among the quarter’s highlights, we produced growth in revenue and adjusted income from continuing operations in excess of 20%, increased our margins and achieved a double-digit increase in same facility revenue. During the quarter, we also announced the acquisition of U.K.-based PiC, the country’s second-largest independent behavioral healthcare provider, which we completed on July 1, 2014. PiC adds 23 inpatient psychiatric facilities with over 1,200 licensed beds to Acadia’s operations and, for 2013, produced revenue of approximately $285 million and adjusted EBITDA of approximately $75 million. In addition to being substantially accretive to our operations, we expect this transaction to position us well in the U.K.’s independent behavioral health market, with meaningful opportunities for organic growth and further acquisitions.
“Acadia’s revenue growth for the second quarter was primarily due to the addition of approximately 675 licensed beds in the 12 months ended June 30, 2014, with 259 added through acquisitions and 416 beds added to existing facilities and two de novo facilities. Our 11.5% growth in same facility revenue reflected the positive impact of the beds added to existing facilities, as well as our continuous efforts to generate additional revenues in each facility. These beds helped produce an increase in patient days of 10.6%. Our second quarter revenue per patient day rose 0.8%.
“The strong operating leverage created by double-digit same facility revenue growth, combined with increased operating efficiencies, produced a 150 basis point increase in our same facility EBITDA margin to 26.3%. The Company’s adjusted consolidated EBITDA increased 20.5% to $44.7 million for the second quarter of 2014.
“Acadia continues to evaluate potential acquisitions and develop new beds in existing facilities. We are well positioned to finance these growth strategies, with availability under our revolving credit facility of approximately $175 million subsequent to the completion of the PiC acquisition and with substantial net cash flows from continuing operations, which totaled approximately $22 million for the second quarter. Including the impact of the PiC transaction, our ratio of total net debt to trailing 12 months adjusted EBITDA is approximately 4.2, compared with 4.2 at the end of the first quarter of 2014.”
Acadia today affirmed its guidance for 2014 adjusted earnings per diluted share in a range of $1.44 to $1.46, which was recently revised from the previous range of $1.26 to $1.29 to account for the accretive impact of the PiC transaction on the second half of 2014. The Company’s guidance does not include the impact of any future acquisitions or transaction-related expenses.
Acadia will hold a conference call to discuss its second quarter financial results at 9:00 a.m. Eastern Time on Wednesday, July 30, 2014. A live webcast of the conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website. The webcast of the conference call will be available through August 12, 2014.
Risk Factors
This news release contains forward-looking statements. Generally words such as “may,” “will,” “should,” “could,” “anticipate,” “expect,” “intend,” “estimate,” “plan,” “continue,” and “believe” or the negative of or other variation on these and other similar expressions identify forward-looking statements. These forward-looking statements are made only as of the date of this news release. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements are based on current expectations and involve risks and uncertainties and our future results could differ significantly from those expressed or implied by our forward-looking statements. Factors that may cause actual results to differ materially include, without limitation, (i) Acadia’s ability to complete acquisitions and successfully integrate the operations of acquired facilities, including the PiC facilities; (ii) Acadia’s ability to add beds, expand services, enhance marketing programs and improve efficiencies at its facilities; (iii) potential reductions in payments received by Acadia from the government and third-party payors; (iv) the occurrence of patient incidents, which could adversely affect the price of our common stock and result in incremental regulatory burdens and governmental investigations; (v) the risk that Acadia may not generate sufficient cash from operations to service its debt and meet its working capital and capital expenditure requirements; and (vi) potential operating difficulties, client preferences, changes in competition and general economic or industry conditions that may prevent Acadia from realizing the expected benefits of its business strategy. These factors and others are more fully described in Acadia’s periodic reports and other filings with the SEC.
About Acadia
Acadia is a provider of inpatient behavioral healthcare services. Acadia operates a network of 75 behavioral healthcare facilities with more than 5,600 licensed beds in 24 states, the United Kingdom and Puerto Rico. Acadia provides psychiatric and chemical dependency services to its patients in a variety of settings, including inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and therapeutic school-based programs.
| Acadia Healthcare Company, Inc. | ||||||||||||||||
| Condensed Consolidated Statements of Operations | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
| 2014 | 2013 | 2014 | 2013 | |||||||||||||
| (in thousands, except per share amounts) | ||||||||||||||||
| Revenue before provision for doubtful accounts | $ | 220,664 | $ | 182,951 | $ | 426,783 | $ | 348,656 | ||||||||
| Provision for doubtful accounts | (6,861 | ) | (5,457 | ) | (11,562 | ) | (9,949 | ) | ||||||||
| Revenue | 213,803 | 177,494 | 415,221 | 338,707 | ||||||||||||
|
Salaries, wages and benefits (including equity-based compensation expense of $2,406, $1,812, $4,170 and $2,413, respectively) |
122,473 | 100,764 | 240,048 | 195,115 | ||||||||||||
| Professional fees | 10,891 | 9,324 | 21,273 | 18,338 | ||||||||||||
| Supplies | 10,596 | 9,613 | 20,660 | 18,211 | ||||||||||||
| Rents and leases | 2,889 | 2,394 | 5,658 | 4,721 | ||||||||||||
| Other operating expenses | 24,646 | 20,096 | 47,756 | 37,079 | ||||||||||||
| Depreciation and amortization | 5,935 | 4,212 | 11,371 | 7,834 | ||||||||||||
| Interest expense, net | 9,730 | 9,445 | 19,437 | 18,207 | ||||||||||||
| Debt extinguishment costs | - | - | - | 9,350 | ||||||||||||
| Gain on foreign currency derivatives | (13,735 | ) | - | (13,735 | ) | - | ||||||||||
| Transaction-related expenses | 3,016 | 1,355 | 4,595 | 2,829 | ||||||||||||
| Total expenses | 176,441 | 157,203 | 357,063 | 311,684 | ||||||||||||
| Income from continuing operations before income taxes | 37,362 | 20,291 | 58,158 | 27,023 | ||||||||||||
| Provision for income taxes | 14,905 | 8,020 | 22,680 | 10,698 | ||||||||||||
| Income from continuing operations | 22,457 | 12,271 | 35,478 | 16,325 | ||||||||||||
| (Loss) income from discontinued operations, net of income taxes | (6 | ) | (74 | ) | 31 | (390 | ) | |||||||||
| Net income | $ | 22,451 | $ | 12,197 | $ | 35,509 | $ | 15,935 | ||||||||
| Basic earnings per share: | ||||||||||||||||
| Income from continuing operations | $ | 0.43 | $ | 0.24 | $ | 0.70 | $ | 0.33 | ||||||||
| (Loss) income from discontinued operations | - | - | - | (0.01 | ) | |||||||||||
| Net income | $ | 0.43 | $ | 0.24 | $ | 0.70 | $ | 0.32 | ||||||||
| Diluted earnings per share: | ||||||||||||||||
| Income from continuing operations | $ | 0.43 | $ | 0.24 | $ | 0.69 | $ | 0.33 | ||||||||
| (Loss) income from discontinued operations | - | - | - | (0.01 | ) | |||||||||||
| Net income | $ | 0.43 | $ | 0.24 | $ | 0.69 | $ | 0.32 | ||||||||
| Weighted-average shares outstanding: | ||||||||||||||||
| Basic | 51,616 | 50,009 | 50,872 | 49,961 | ||||||||||||
| Diluted | 51,819 | 50,282 | 51,174 | 50,196 | ||||||||||||
| Acadia Healthcare Company, Inc. | ||||||
| Condensed Consolidated Balance Sheets | ||||||
| (Unaudited) | ||||||
| June 30, | December 31, | |||||
| 2014 | 2013 | |||||
| (In thousands) | ||||||
| ASSETS | ||||||
| Current assets: | ||||||
| Cash and cash equivalents | $ | 277,744 | $ | 4,569 | ||
| Accounts receivable, net of allowance for doubtful accounts of $19,894 and $18,345, respectively | 110,904 | 95,885 | ||||
| Deferred tax assets | 12,756 | 15,703 | ||||
| Other current assets | 48,192 | 28,969 | ||||
| Total current assets | 449,596 | 145,126 | ||||
| Property and equipment, net | 419,386 | 370,109 | ||||
| Goodwill | 665,695 | 661,549 | ||||
| Intangible assets, net | 20,852 | 20,568 | ||||
| Deferred tax assets - noncurrent | 4,227 | - | ||||
| Other assets | 32,796 | 27,307 | ||||
| Total assets | $ | 1,592,552 | $ | 1,224,659 | ||
| LIABILITIES AND EQUITY | ||||||
| Current liabilities: | ||||||
| Current portion of long-term debt | $ | 11,445 | $ | 15,195 | ||
| Accounts payable | 31,515 | 36,026 | ||||
| Accrued salaries and benefits | 39,445 | 37,721 | ||||
| Other accrued liabilities | 20,260 | 25,748 | ||||
| Total current liabilities | 102,665 | 114,690 | ||||
| Long-term debt | 555,812 | 601,941 | ||||
| Deferred tax liabilities - noncurrent | 17,894 | 7,971 | ||||
| Other liabilities | 20,959 | 19,347 | ||||
| Total liabilities | 697,330 | 743,949 | ||||
| Equity: | ||||||
| Common stock | 592 | 501 | ||||
| Additional paid-in capital | 840,719 | 461,807 | ||||
| Retained earnings | 53,911 | 18,402 | ||||
| Total equity | 895,222 | 480,710 | ||||
| Total liabilities and equity | $ | 1,592,552 | $ | 1,224,659 | ||
| Acadia Healthcare Company, Inc. | ||||||||
| Condensed Consolidated Statements of Cash Flows | ||||||||
| (Unaudited) | ||||||||
| Six Months Ended June 30, | ||||||||
| 2014 | 2013 | |||||||
| (In thousands) | ||||||||
| Operating activities: | ||||||||
| Net income | $ | 35,509 | $ | 15,935 | ||||
| Adjustments to reconcile net income to net cash provided by continuing operating activities: | ||||||||
| Depreciation and amortization | 11,371 | 7,834 | ||||||
| Amortization of debt issuance costs | 1,334 | 1,110 | ||||||
| Equity-based compensation expense | 4,170 | 2,413 | ||||||
| Deferred income tax expense | 9,097 | 5,392 | ||||||
| (Income) loss from discontinued operations, net of taxes | (31 | ) | 390 | |||||
| Debt extinguishment costs | - | 9,350 | ||||||
| Gain on foreign currency derivatives | (13,735 | ) | - | |||||
| Other | 25 | 14 | ||||||
| Change in operating assets and liabilities, net of effect of acquisitions: | ||||||||
| Accounts receivable, net | (15,303 | ) | (10,557 | ) | ||||
| Other current assets | (4,792 | ) | 107 | |||||
| Other assets | (578 | ) | (807 | ) | ||||
| Accounts payable and other accrued liabilities | (1,300 | ) | 1,038 | |||||
| Accrued salaries and benefits | 1,782 | (3,074 | ) | |||||
| Other liabilities | 1,701 | 458 | ||||||
| Net cash provided by continuing operating activities | 29,250 | 29,603 | ||||||
| Net cash used in discontinued operating activities | (11 | ) | (358 | ) | ||||
| Net cash provided by operating activities | 29,239 | 29,245 | ||||||
| Investing activities: | ||||||||
| Cash paid for acquisitions, net of cash acquired | (10,000 | ) | (121,731 | ) | ||||
| Cash paid for capital expenditures | (43,323 | ) | (29,709 | ) | ||||
| Cash paid for real estate acquisitions | (18,326 | ) | (3,959 | ) | ||||
| Other | (439 | ) | (554 | ) | ||||
| Net cash used in investing activities | (72,088 | ) | (155,953 | ) | ||||
| Financing activities: | ||||||||
| Borrowings on long-term debt | 7,500 | 150,000 | ||||||
| Borrowings on revolving credit facility | 59,500 | 8,000 | ||||||
| Principal payments on revolving credit facility | (113,000 | ) | (8,000 | ) | ||||
| Principal payments on long-term debt | (3,750 | ) | (1,875 | ) | ||||
| Repayment of long-term debt | - | (52,500 | ) | |||||
| Payment of debt issuance costs | (5,810 | ) | (4,307 | ) | ||||
| Payment of premium on note redemption | - | (6,759 | ) | |||||
| Issuance of common stock, net | 374,336 | - | ||||||
| Common stock withheld for minimum statutory taxes, net | (2,981 | ) | (1,062 | ) | ||||
| Excess tax benefit from equity awards | 3,479 | 1,211 | ||||||
| Cash paid for contingent consideration | (3,250 | ) | - | |||||
| Net cash provided by financing activities | 316,024 | 84,708 | ||||||
| Net increase (decrease) in cash and cash equivalents | 273,175 | (42,000 | ) | |||||
| Cash and cash equivalents at beginning of the period | 4,569 | 49,399 | ||||||
| Cash and cash equivalents at end of the period | $ | 277,744 | $ | 7,399 | ||||
| Effect of acquisitions: | ||||||||
| Assets acquired, excluding cash | $ | 10,500 | $ | 146,062 | ||||
| Liabilities assumed | - | (12,647 | ) | |||||
| Prior year deposits paid for acquisitions | (500 | ) | (11,684 | ) | ||||
| Cash paid for acquisitions, net of cash acquired | $ | 10,000 | $ | 121,731 | ||||
| Acadia Healthcare Company, Inc. | |||||||||||||||||||||||
| Operating Statistics | |||||||||||||||||||||||
| (Unaudited) | |||||||||||||||||||||||
| (Revenue in thousands) | |||||||||||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2014 | 2013 | % Change | 2014 | 2013 | % Change | ||||||||||||||||||
| Same Facility Results | |||||||||||||||||||||||
| Revenue | $ | 196,981 | $ | 176,743 | 11.5% | $ | 373,391 | $ | 337,297 | 10.7% | |||||||||||||
| Patient Days | 294,156 | 265,914 | 10.6% | 558,778 | 512,190 | 9.1% | |||||||||||||||||
| Admissions | 16,472 | 14,197 | 16.0% | 30,568 | 27,066 | 12.9% | |||||||||||||||||
| Average Length of Stay (a) | 17.9 | 18.7 | -4.7% | 18.3 | 18.9 | -3.4% | |||||||||||||||||
| Revenue per Patient Day | $ | 670 | $ | 665 | 0.8% | $ | 668 | $ | 659 | 1.5% | |||||||||||||
| EBITDA margin | 26.3% | 24.8% | 150 bps | 26.1% | 24.0% | 210 bps | |||||||||||||||||
| Total Facility Results | |||||||||||||||||||||||
| Revenue | $ | 212,834 | $ | 176,743 | 20.4% | $ | 413,398 | $ | 337,297 | 22.6% | |||||||||||||
| Patient Days | 315,710 | 265,914 | 18.7% | 612,767 | 512,190 | 19.6% | |||||||||||||||||
| Admissions | 18,908 | 14,197 | 33.2% | 36,826 | 27,066 | 36.1% | |||||||||||||||||
| Average Length of Stay (a) | 16.7 | 18.7 | -10.9% | 16.6 | 18.9 | -12.1% | |||||||||||||||||
| Revenue per Patient Day | $ | 674 | $ | 665 | 1.4% | $ | 675 | $ | 659 | 2.4% | |||||||||||||
| EBITDA margin | 24.9% | 24.8% | 10 bps | 24.3% | 24.0% | 30 bps | |||||||||||||||||
| (a) Average length of stay is defined as patient days divided by admissions. | |||||||||||||||||||||||
| Acadia Healthcare Company, Inc. | ||||||||||||||
| Reconciliation of Net Income to Adjusted EBITDA | ||||||||||||||
| (Unaudited) | ||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||
| 2014 | 2013 | 2014 | 2013 | |||||||||||
| (in thousands) | ||||||||||||||
| Net income | $ | 22,451 | $ | 12,197 | $ | 35,509 | $ | 15,935 | ||||||
| (Income) loss from discontinued operations | 6 | 74 | (31 | ) | 390 | |||||||||
| Provision for income taxes | 14,905 | 8,020 | 22,680 | 10,698 | ||||||||||
| Interest expense, net | 9,730 | 9,445 | 19,437 | 18,207 | ||||||||||
| Depreciation and amortization | 5,935 | 4,212 | 11,371 | 7,834 | ||||||||||
| EBITDA | 53,027 | 33,948 | 88,966 | 53,064 | ||||||||||
| Adjustments: | ||||||||||||||
| Equity-based compensation expense (a) | 2,406 | 1,812 | 4,170 | 2,413 | ||||||||||
| Debt extinguishment costs (b) | - | - | - | 9,350 | ||||||||||
| Gain on foreign currency derivatives (c) | (13,735 | ) | - | (13,735 | ) | - | ||||||||
| Transaction-related expenses (d) | 3,016 | 1,355 | 4,595 | 2,829 | ||||||||||
| Adjusted EBITDA | $ | 44,714 | $ | 37,115 | $ | 83,996 | $ | 67,656 | ||||||
| See footnotes on page 10. | ||||||||||||||
| Acadia Healthcare Company, Inc. | ||||||||||||||||
| Reconciliation of Adjusted Income from Continuing Operations to Income from | ||||||||||||||||
| Continuing Operations | ||||||||||||||||
| (Unaudited) | ||||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
| 2014 | 2013 | 2014 | 2013 | |||||||||||||
| (in thousands, except per share amounts) | ||||||||||||||||
| Income from continuing operations | $ | 22,457 | $ | 12,271 | $ | 35,478 | $ | 16,325 | ||||||||
| Provision for income taxes | 14,905 | 8,020 | 22,680 | 10,698 | ||||||||||||
| Income from continuing operations before income taxes | 37,362 | 20,291 | 58,158 | 27,023 | ||||||||||||
| Adjustments to income from continuing operations: | ||||||||||||||||
| Debt extinguishment costs (b) | - | - | - | 9,350 | ||||||||||||
| Gain on foreign currency derivatives (c) | (13,735 | ) | - | (13,735 | ) | - | ||||||||||
| Transaction-related expenses (d) | 3,016 | 1,355 | 4,595 | 2,829 | ||||||||||||
|
Income tax provision reflecting tax effect of adjustments to income from continuing operations (e) |
(10,047 | ) | (8,554 | ) | (18,406 | ) | (15,520 | ) | ||||||||
| Adjusted income from continuing operations | $ | 16,596 | $ | 13,092 | $ | 30,612 | $ | 23,682 | ||||||||
| Weighted-average shares outstanding - diluted | 51,819 | 50,282 | 51,174 | 50,196 | ||||||||||||
| Adjusted income from continuing operations per diluted share | $ | 0.32 | $ | 0.26 | $ | 0.60 | $ | 0.47 | ||||||||
| See footnotes on page 10. | ||||||||||||||||
| Footnotes | ||
| We have included certain financial measures in this press release, including EBITDA, Adjusted EBITDA and Adjusted income from continuing operations, which are “non-GAAP financial measures” as defined under the rules and regulations promulgated by the SEC. We define EBITDA as net income adjusted for loss (income) from discontinued operations, net interest expense, income tax provision and depreciation and amortization. We define Adjusted EBITDA as EBITDA adjusted for equity-based compensation expense, debt extinguishment costs, gain on foreign currency derivatives and transaction-related expenses. | ||
| EBITDA, Adjusted EBITDA and Adjusted income from continuing operations are supplemental measures of our performance and are not required by, or presented in accordance with, generally accepted accounting principles in the United States (“GAAP”). EBITDA, Adjusted EBITDA and Adjusted income from continuing operations are not measures of our financial performance under GAAP and should not be considered as alternatives to net income or any other performance measures derived in accordance with GAAP or as an alternative to cash flow from operating activities as measures of our liquidity. Our measurements of EBITDA, Adjusted EBITDA and Adjusted income from continuing operations may not be comparable to similarly titled measures of other companies. We have included information concerning EBITDA, Adjusted EBITDA and Adjusted income from continuing operations in this press release because we believe that such information is used by certain investors as measures of a company’s historical performance. We believe these measures are frequently used by securities analysts, investors and other interested parties in the evaluation of issuers of equity securities, many of which present EBITDA, Adjusted EBITDA and Adjusted income from continuing operations when reporting their results. Our presentation of EBITDA, Adjusted EBITDA and Adjusted income from continuing operations should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items. | ||
| (a) Represents the equity-based compensation expense of Acadia. | ||
| (b) Represents debt extinguishment costs related to the repayment of $52.5 million of the Company's 12.875% Senior Notes due 2018 on March 12, 2013, including a prepayment premium of $6.8 million and the write-off of $2.6 million of deferred financing costs. | ||
| (c) Represents the change in fair value of foreign currency derivatives purchased by Acadia related to its acquisition of Partnerships in Care on July 1, 2014. | ||
| (d) Represents transaction-related expenses incurred by Acadia related to acquisitions. | ||
| (e) Represents the income tax provision adjusted to reflect the tax effect of the adjustments to income from continuing operations based on effective tax rates excluding the impact of non-deductible transaction-related expenses. | ||
CONTACT:
Acadia Healthcare Company, Inc.
Brent Turner, 615-861-6000
President